PB-PE VQR
(Plasmid
#162797)
-
PurposeAll-in-one prime editor piggyBac transposon, VQR variant
-
Depositing Lab
-
Depositing OrganizationMedizinische Hochschule Hannover
Located in Germany -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 162797 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
| DNA | 162797-D50 | 50 μg of DNA in Tris buffer | $495 | ||
| DNA | 162797-D100 | 100 μg of DNA in Tris buffer | $585 | ||
Backbone
-
Vector backbonepEX-A2
-
Backbone manufacturerEurofins Genomics
- Backbone size w/o insert (bp) 5120
- Total vector size (bp) 13136
-
Modifications to backboneaddition of 3' and 5' piggyBac repeats, addition of pU6-pegRNA(B12B) sequence, addition of CAG promoter, addition of bGH (pA)
-
Vector typeMammalian Expression, CRISPR, Synthetic Biology ; piggyBac transposon
-
Selectable markersPuromycin ; thymidine kinase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Growth instructionsIt is highly recommened to use NEB Stable at 30°C. Cloning efficiency and stability of plasmid can be compromised when using other strains / higher temperatures!
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameSpCas9_H840A_VQR-PE2-MMLV-RT(dBB)-P2A-PAC_dTK(dBB)
-
SpeciesSynthetic
-
Insert Size (bp)8016
-
MutationD1135V, R1335Q, T1337R
- Promoter CAG
-
Tags
/ Fusion Proteins
- SV40 NLS (N terminal on insert)
- SV40 NLS (C terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer GGGCAGGAAGAGGGCCTAT
- 3′ sequencing primer CCTCGACTGTGCCTTCTA
- (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byVQR-containing region of Cas9_H840A_VQR was PCR amplified from lenti-Cas9-VQR-Blast (Addgene #87155)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
DNA (Catalog # 162797-D50)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 50 μg
- Concentration 1 μg/μL
- Pricing $495 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
DNA (Catalog # 162797-D100)
Purpose
Ready-to-use, high-purity DNA prep. DNA aliquots are suitable for use in mammalian cell transfections and other molecular biology applications.
Delivery
- Amount 100 μg
- Concentration 1 μg/μL
- Pricing $585 USD
- Storage 4 ℃ (short-term) or -20 ℃ (long-term)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Quality Control
Every DNA prep is verified by next-generation sequencing, confirming plasmid identity, sequence integrity, and absence of DNA contaminants. Concentration is confirmed to be within ±2.5% of the stated concentration.
Our production process has been validated to consistently yield endotoxin levels below 1.0 EU/μg. Individual lots are not tested for endotoxin.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PB-PE VQR was a gift from Tobias Cantz (Addgene plasmid # 162797 ; http://n2t.net/addgene:162797 ; RRID:Addgene_162797) -
For your References section:
A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines. Eggenschwiler R, Gschwendtberger T, Felski C, Jahn C, Langer F, Sterneckert J, Hermann A, Luhmann J, Steinemann D, Haase A, Martin U, Petri S, Cantz T. Sci Rep. 2021 Nov 12;11(1):22154. doi: 10.1038/s41598-021-01689-2. 10.1038/s41598-021-01689-2 PubMed 34773059